GVR Report cover Myopia And Presbyopia Treatment Market Size, Share & Trend Report

Myopia And Presbyopia Treatment Market Size, Share & Trend Analysis Report By Myopia Treatment Type (Corrective, Surgical), By Presbyopia Treatment Type (Prescription, Contact Lenses), By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-3-68038-678-3
  • Number of Report Pages: 110
  • Format: PDF, Horizon Databook
  • Historical Range: 2017 - 2021
  • Forecast Period: 2023 - 2030 
  • Industry: Healthcare

Market Size & Trends

The global myopia and presbyopia treatment market size was valued at USD 17.44 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 8.8% from 2023 to 2030. Increasing cases of vision loss mainly due to myopia and rising incidence of distance vision impairment due to uncorrected myopia, are some of the major factors expected to augment the overall market growth. In addition, growing prevalence of presbyopia on the global scale is expected to foster the growth of the market over the forecast period. More than 2.1 billion individuals around the world suffered from presbyopia in 2020. Out of these individuals, one third are aged more than 50 years. Nearly 128 million people in the U.S. are prevalent to presbyopia. According to WHO, in 2020, nearly 826 million are affected by unaddressed presbyopia. Also, the number of presbyopia is the largest in East Asia, South Asia and Southeast Asia, reporting more than twice as that of other regions. Hence the developing countries are expected to exhibit significant market demand during the forecast period.

Canada myopia treatment market size and growth rate, 2023 - 2030

Growing geriatric population that is prone to vision loss and ageing adults (individuals of above 40 years of age) across the globe is fueling the market growth. Most adults, in their mid-40s start developing age and lifestyle associated vision myopia treatment types. These myopia treatment types are expected to grow into myopia and presbyopia, thus augmenting the demand for myopia and presbyopia treatment. Undiagnosed presbyopia is one of the major challenges which is expected to have a high impact on vision care industry. The pathophysiology of presbyopia is still unclear to many people, thereby, resulting into late diagnosis and increased treatment costs.

People already affected with myopia or presbyopia have started opting for telemedicine in the midst of COVID-19. With widespread adoption of telemedicine, eye care professionals and regular consultants are continuing for monitoring of myopia progression, creating minimal impact on market growth. Many medical practices and hospitals are affected during the COVID-19 pandemic owing to several changes in protocols. The ophthalmology procedures are also affected in this novel disease outbreak as health checkups including ophthalmology were reduced due to COVID-19 restrictions. Due to increased risk of spreading infection through contact lens, many people opt for LASIK surgery for vision correction. Such reductions in elective ophthalmic surgeries is anticipated to create negative impact on the overall market growth.

Additionally, introduction of advanced lenses such as intraocular phakic presbyopic lenses and implantable contact lenses, is expected to drive the market growth during the forecast period. These lenses are expected to gain enough popularity owing to its benefits, such as capability of correcting significant degree of nearsightedness, less prone to dry eyes, can be surgically removed, and can be ideally used for non-LASIK patients.

PresbyLASIK is one of the advanced options available for correction of presbyopia. This involves usage of laser therapy for inducing spherical aberration to make cornea multifocal. Another, advanced option for presbyopic patients includes corneal inlays. Currently only two corneal inlays are approved for the correction of presbyopia. Increasing number of ongoing studies and wide product pipeline are the factors expected to boost the market growth.

Myopia Treatment Type Insights

Single prescription lenses segment held around 31.9% in 2022. This is due to the increasing prevalence of myopia in developing countries. The growing patient pool is contributing to the growing demand for corrective lenses. Features of the surgery such as minimally invasiveness, accuracy, and speed are also affecting the popularity of the surgery, thereby driving the adoption of myopia and presbyopia treatment.

Technologically advanced solutions are helping to significantly decrease the average turnaround time for ophthalmic surgeries. The increasing availability of advanced equipment and decreasing service costs are expected to boost the demand for surgeries during the forecast period.

Presbyopia Treatment Type Insights

Prescription lens captured largest market share of more than 29.6% in 2022. Contact lenses is also categorized as bifocal, multifocal, monovision, and modified monovision. Conductive keratoplasty, LASIK, LASEK, and PRK are effective refractive surgical procedures used for the treatment of presbyopia. LASIK is widely accepted surgical procedure for the treatment of presbyopia. The surgery involves reshaping of the cornea to improve far vision. Hence, high prevalence of these myopia treatment types and growing demand for LASIK surgery is expected to foster the market growth during the forecast period.

Global myopia and presbyopia treatment market share and size, 2022

Progressive multifocals segment is expected to be the fastest growing segment owing to increasing preference for correcting presbyopia. They are widely accepted due to aesthetic and visual advantages, such as image clarity while rejecting image jumping during eye movements. In addition, innovations in multifocals, such as multifocals incorporated with anti-reflexive coating and photochromic lenses, is also expected to propel the growth of the segment during the forecast period.

Regional Insights

Asia Pacific dominated the market with around 25.5% in 2022 and is expected to hold maximum share of the myopia and presbyopia treatment market owing to availability of advanced technologies for treating the targeted myopia treatment types and presence of large number of market players.

Myopia And Presbyopia Treatment Market Trends, by Region, 2023 - 2030

The region is expected to be the fastest-growing region over the forecast period owing to geriatric population growth, high prevalence of eye-related myopia treatment types, and growing medical tourism. In addition, rising disposable income of consumers is also expected to drive the market in the region.

Key Companies & Market Share Insights

Market players are focusing on adopting growth strategies, such as innovations in the existing technologies, launch of efficient techniques, mergers and acquisition, and others. Heavy investment in R&D is undertaken by market leaders to enable early diagnosis and identify efficient and quick operative techniques. This ensures novelty in the field and concretes market position. Increased collaborations undertaken by major players like Johnson and Johnson, Essilor, Zeimer Ophthalmic Systems AG, and many others, to develop advanced techniques and treatment strategies to provide improved and efficient treatment for myopia and presbyopia.  In July 2021, Essilor launched a progressive web app version of the pre-existing Essilor Companion for all eye care professionals. This initiative aims to streamline the digital ecosystem for Essilor’s industry partners, including Eye Care Professionals (ECPs), as well as offers a superior in-store digital Essilor brand experience. Such initiatives are likely to enhance their market presence. Some of the players profiled in the global myopia and presbyopia treatment market include:

  • Ziemer Ophthalmic Systems AG


  • Johnson & Johnson Vision

  • Essilor Ltd.

  • Zeiss International


  • Bausch & Lomb Incorporated

  • Haag-Streit UK

  • Topcon Corporation

Myopia And Presbyopia Treatment Market Report Scope

Report Attribute


The market size value in 2023

USD 18.7 billion

Revenue forecast in 2030

USD 33.7 billion

Growth rate

CAGR of 8.8% from 2023 to 2030

Base year for estimation


Historical data

2017 - 2021

Forecast period

2023 - 2030

Report updated

June 2023

Quantitative units

Revenue in USD million/billion, and CAGR from 2023 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Type, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; India; China; Thailand; South Korea; Brazil; Mexico; Argentina; Columbia; South Africa; Saudi Arabia; UAE

Key companies profiled

Ziemer Ophthalmic Systems AG; NIDEK CO. LTD.; Johnson & Johnson Vision; Essilor Ltd.; Zeiss International; ALCON VISION LLC; Bausch & Lomb Incorporated; Haag-Streit UK; Topcon Corporation.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail of customized purchase options to meet your exact research needs. Explore purchase options


Global Myopia And Presbyopia Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the global myopia and presbyopia treatment market report on the basis of type and region:

  • Myopia Treatment Type Outlook (Revenue, USD Million, 2017 - 2030)

    • Corrective

      • Prescription Lenses

        • Single

        • Bifocal

        • Trifocal

        • Others

      • Contact Lenses

    • Surgical

    • Drugs

  • Presbyopia Treatment Type Outlook (Revenue, USD Million, 2017 - 2030)

    • Prescription Lenses

      • Reading Glasses

      • Bifocals

      • Trifocals

      • Progressive Multifocals

      • Office Progressives

    • Contact Lenses

      • Bifocal

      • Multifocal

      • Monovision

      • Modified Monovision

    • Intraocular Lenses

    • Refractive Surgery

  • Regional Outlook (Revenue, USD Million, 2017 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

    • Asia Pacific

      • China

      • Japan

      • India

      • Thailand

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Columbia

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.